These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Epidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. Mabuchi T; Takekoshi T; Hwang ST J Immunol; 2011 Nov; 187(10):5026-31. PubMed ID: 21984702 [TBL] [Abstract][Full Text] [Related]
6. Accumulation and activation of epidermal γδ T cells in a mouse model of chronic dermatitis is not required for the inflammatory phenotype. Sulcova J; Maddaluno L; Meyer M; Werner S Eur J Immunol; 2015 Sep; 45(9):2517-28. PubMed ID: 26081170 [TBL] [Abstract][Full Text] [Related]
7. Chronic proliferative dermatitis in Sharpin null mice: development of an autoinflammatory disease in the absence of B and T lymphocytes and IL4/IL13 signaling. Potter CS; Wang Z; Silva KA; Kennedy VE; Stearns TM; Burzenski L; Shultz LD; Hogenesch H; Sundberg JP PLoS One; 2014; 9(1):e85666. PubMed ID: 24465642 [TBL] [Abstract][Full Text] [Related]
8. Cutting Edge: PD-1 Regulates Imiquimod-Induced Psoriasiform Dermatitis through Inhibition of IL-17A Expression by Innate γδ-Low T Cells. Imai Y; Ayithan N; Wu X; Yuan Y; Wang L; Hwang ST J Immunol; 2015 Jul; 195(2):421-5. PubMed ID: 26048148 [TBL] [Abstract][Full Text] [Related]
9. Barrier abnormality due to ceramide deficiency leads to psoriasiform inflammation in a mouse model. Nakajima K; Terao M; Takaishi M; Kataoka S; Goto-Inoue N; Setou M; Horie K; Sakamoto F; Ito M; Azukizawa H; Kitaba S; Murota H; Itami S; Katayama I; Takeda J; Sano S J Invest Dermatol; 2013 Nov; 133(11):2555-2565. PubMed ID: 23633022 [TBL] [Abstract][Full Text] [Related]
10. Suppression of IL-17A-induced CCL20 production by cytokine inducible SH2-containing protein 1 in epidermal keratinocytes. Tohyama M; Matsumoto A; Tsuda T; Dai X; Shiraishi K; Sayama K J Dermatol Sci; 2021 Mar; 101(3):202-209. PubMed ID: 33509657 [TBL] [Abstract][Full Text] [Related]
11. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo. Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202 [TBL] [Abstract][Full Text] [Related]
12. GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation. Jones SA; Perera DN; Fan H; Russ BE; Harris J; Morand EF J Autoimmun; 2015 Jul; 61():73-80. PubMed ID: 26077873 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222 [TBL] [Abstract][Full Text] [Related]
14. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells. Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075 [TBL] [Abstract][Full Text] [Related]
15. CXCR4 negatively regulates keratinocyte proliferation in IL-23-mediated psoriasiform dermatitis. Takekoshi T; Wu X; Mitsui H; Tada Y; Kao MC; Sato S; Dwinell MB; Hwang ST J Invest Dermatol; 2013 Nov; 133(11):2530-2537. PubMed ID: 23528817 [TBL] [Abstract][Full Text] [Related]
16. GATA3 expression is decreased in psoriasis and during epidermal regeneration; induction by narrow-band UVB and IL-4. Rácz E; Kurek D; Kant M; Baerveldt EM; Florencia E; Mourits S; de Ridder D; Laman JD; van der Fits L; Prens EP PLoS One; 2011; 6(5):e19806. PubMed ID: 21611195 [TBL] [Abstract][Full Text] [Related]
17. Blockade of TNF receptor superfamily 1 (TNFR1)-dependent and TNFR1-independent cell death is crucial for normal epidermal differentiation. Piao X; Miura R; Miyake S; Komazawa-Sakon S; Koike M; Shindo R; Takeda J; Hasegawa A; Abe R; Nishiyama C; Mikami T; Yagita H; Uchiyama Y; Nakano H J Allergy Clin Immunol; 2019 Jan; 143(1):213-228.e10. PubMed ID: 29596938 [TBL] [Abstract][Full Text] [Related]